New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.

New research from researchers at the University of Florida, University of Maryland and Yale School of Public Health has found that if measles, mumps and rubella (MMR) immunization rates continue to ...

Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...

Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a ...

April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offerings ...

In this edition of the biotech bi-weekly, get the latest biotech industry updates, with special focus on the upcoming AACR ...

CHENGDU, China, April 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) announced that results from both the ovarian cancer cohort ...

Sovereign wealth funds from Singapore and Abu Dhabi join Chinese state capital as cross-border biotech licensing reaches ...

ASX biotech shares are trading at valuations that lag those of the US Nasdaq index. This discrepancy won't last, experts say.

Initial data from first cohort in LA-PDAC show 66% (2/3) patients resected following VTP at lowest light dose with a consistent and well-tolerated safety profile - ...

Orthocell Ltd (ASX:OCC, OTC:ORHHF)’s push into the US market is starting to put real numbers behind a long-anticipated ...

Immutep shares rocket after a fresh FDA win The post Why this ASX biotech stock just rocketed 89% today appeared first on The ...